Vitamin D receptor BsmI haplotype BB confers lower 25(OH)D levels during tuberculosis: a pilot cross-sectional study
Therapeutic Advances in Infectious Disease · 2026-06 · 13
DOI: 10.1177/20499361261458154 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Therapeutic Advances in Infectious Disease, online erschienen am 30.06.2026. Verfasst von Dilcia Sambrano und 17 weiteren Autor:innen. Beteiligte Einrichtung: Tuberculosis Biomarker Research Unit, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), Ciudad del Saber, Pana…. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Secretaria Nacional de Ciencia Tecnología e Innovación.
Abstract (Originalsprache)
Background
Adequate micronutrient absorption remains key for tuberculosis control.
Objective
To evaluate the frequency of vitamin D receptor polymorphisms, FokI , TaqI , and BsmI , and their relationship with total vitamin D and cathelicidin levels in patients with pulmonary tuberculosis (PTB) and healthy controls (HC) in the province of Colon, Panama.
Design
Pilot cross-sectional study, PTB ( n = 80) and HC ( n = 50).
Methods
We measured total vitamin D (25-OH-vitamin D, 25(OH)D) and cathelicidin (LL-37) levels by enzyme-linked immunosorbent assays and analyzed vitamin D receptor (VDR) polymorphisms by PCR-RFLP. We compared the total 25(OH)D and cathelicidin levels across participant demographics and explored the associations with vitamin D receptor polymorphisms.
Results
We observed no significant difference in vitamin D levels between PTB and HC (median (IQR) = 36.6 (27.6–48.7) ng/mL and 32.5 (18–46.3) ng/mL, respectively, p = 0.067). In terms of sex, vitamin D levels in women were higher in the PTB group compared to HC (median (IQR) = 33.9 (26.8–48.1) versus 19.5 (11.8–33.4) ng/mL, p = 0.002). Regarding LL-37, PTB unemployed participants showed higher levels compared to HC (median (IQR) = 59.4 (42.4–79.3) versus 28.2 (13.9–42.8) ng/mL, p = 0.048), as well as Hispanic PTBs (59.6 (48.2–71.41) versus 38.9 (19.5–49.2) ng/mL, p = 0.014). As for the treatment phase, vitamin D levels in PTB within 1 month of treatment were higher than HC (median (IQR) = 39.9 (28.5–50.51) versus 32.5 (18–46.3) ng/mL, p = 0.06). When stratifying by sex, these differences were observed only in women (median (IQR) = 41.4 (27.9–55.5) versus 19.5 (11.8–33.4) ng/mL for PTB and HC, respectively; p = 0.01). A statistically significant association was observed between the BsmI VDR polymorphism and serum 25-hydroxyvitamin D levels, with a significant difference between PTB and HC ( p = 0.004).
Conclusion
The observed associations between VDR polymorphisms, vitamin D levels, and cathelicidin levels highlight the need for further studies to clarify the role of host genetic and sociodemographic factors in pulmonary tuberculosis susceptibility and immune response.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tuberculosis Biomarker Research Unit, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), Ciudad del Saber, Panamá.
- Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.
- CIBER of Epidemiology and Public Health (CIBERESP-Spain), Madrid, Spain.
- Universidad Latina de Panamá, Panamá, Panamá.
- Sistema Nacional de Investigación (SNI-AIP), Ciudad del Saber, Panamá.
- Departamento de Fisiología y Comportamiento Animal, Universidad de Panamá, Panamá, Panamá.
ORCID-Profile: Dilcia Sambrano, Sandra Martín-Peláez, Priya Patel, Fermín Acosta, Johanna Elizabeth Ku, Anabel Argelis García, Emilio Romero, Amador Goodridge
Förderung
- Secretaria Nacional de Ciencia Tecnología e Innovación
Zitieren
APA
Sambrano, D., Martín-Peláez, S., Salazar, K., Patel, P., Acosta, F., Ku, J. E., García, A. A., Romero, E., Cuadra, Y., Hawkins, S., Martínez, I., Luque, O., Solís, L., Cañate, G., Vergara, M., Garibaldi, L., Jurado, J., & Goodridge, A. (2026). Vitamin D receptor BsmI haplotype BB confers lower 25(OH)D levels during tuberculosis: a pilot cross-sectional study. Therapeutic Advances in Infectious Disease, 13. https://doi.org/10.1177/20499361261458154
Vancouver
Sambrano D, Martín-Peláez S, Salazar K, Patel P, Acosta F, Ku JE, et al. Vitamin D receptor BsmI haplotype BB confers lower 25(OH)D levels during tuberculosis: a pilot cross-sectional study. Therapeutic Advances in Infectious Disease. 2026;13. doi:10.1177/20499361261458154
BibTeX
@article{Sambrano2026,
author = {Sambrano, Dilcia and Martín-Peláez, Sandra and Salazar, Kharla and Patel, Priya and Acosta, Fermín and Ku, Johanna Elizabeth and García, Anabel Argelis and Romero, Emilio and Cuadra, Yaracelis and Hawkins, Stephanie and Martínez, Isolina and Luque, Odemaris and Solís, Laura and Cañate, Geydi and Vergara, Mariela and Garibaldi, Lizbeth and Jurado, Julio and Goodridge, Amador},
title = {Vitamin D receptor BsmI haplotype BB confers lower 25(OH)D levels during tuberculosis: a pilot cross-sectional study},
journal = {Therapeutic Advances in Infectious Disease},
year = {2026},
volume = {13},
doi = {10.1177/20499361261458154}
}
EUVIMED